Phico Therapeutics Ltd, a Cambridge-based company that has developed a unique anti-bacterial technology to treat the hospital superbug, MRSA, has raised £550,000 with the help of Oxfordshire Investment Opportunity Network (OION), Europe’s leading technology business angel network. Phico’s anti-bacterial technology, known as SASPject, is effective against all bacteria but can uniquely be targeted to destroy only harmful bacteria while leaving “good” skin and gut bacteria intact. The funding will enable Phico to take SASPject through to clinical trials.
Dr Heather Fairhead, Chief Executive Officer of Phico Therapeutics, said: “Phico’s anti-bacterial SASPject technology is effectively a lethal injection for bacteria. Uniquely, SASPject combines an anti-bacterial protein (SASP) with a delivery vector programmed to inject the SASP protein directly into selected bacteria, so it wipes out only harmful bacteria. It is expected to have far fewer side effects than conventional antibiotics.
SASPject can de-activate or ‘turn off’ bacterial DNA, putting bacteria into a state of suspended animation and halting the spread of infection, giving the immune system time to eliminate the bacteria. It is extremely effective against antibiotic resistant bacteria, such as the MRSA superbug, with SASPject turning off the genes that cause resistance to antibiotics. Conventional antibiotics cannot do this.”
Not of Divided Mind
19.01.2017 | Hertie-Institut für klinische Hirnforschung (HIH)
CRISPR meets single-cell sequencing in new screening method
19.01.2017 | CeMM Forschungszentrum für Molekulare Medizin der Österreichischen Akademie der Wissenschaften
An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...
Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...
Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.
While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...
Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales
Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...
Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.
As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...
19.01.2017 | Event News
10.01.2017 | Event News
09.01.2017 | Event News
19.01.2017 | Earth Sciences
19.01.2017 | Life Sciences
19.01.2017 | Physics and Astronomy